EUVIMEDEUVIMED entdecken
Open Access

Supramolecular STING‐Hydrogel Spatiotemporally Boosts Tumor‐Derived Extracellular Vesicle‐Based Personalized Vaccine for Enhanced Cancer Immunotherapy

Minglu Tang, Chenwei Jiang iD, Mingmei Guo, Qi Chen, Qi Shang, Lin Xiong, Wen Zhang, Liang Dong iD, Qi Yue, Xihui Gao iD, Feihu Wang iD

Advanced Materials · 2026-08 · 38 (48)

DOI: 10.1002/adma.74204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 18.07.2026. Verfasst von Minglu Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Extracellular Vesicles, Immunotherapy, Hydrogels. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Medicine Engineering Joint Foundation of Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Personalized vaccines represent a promising approach for cancer treatment by eliciting tumor‐specific immune responses. However, their development faces persistent challenges, including the laborious and costly process of neoantigen identification, which substantially delays vaccine production. Moreover, conventional platforms suffer from rapid systemic clearance and inefficient delivery to antigen‐presenting cells (APCs), leading to only transient and weak immune activation. Here, we report a STING‐agonist‐integrated hydrogel system designed for localized delivery of tumor‐derived extracellular vesicles (TEVs) to achieve robust and durable antitumor immunity. Upon subcutaneous administration, the in situ formed hydrogel vaccine acts as a depot for antigen‐rich TEVs and STING agonists. We demonstrate that this vaccine promotes dendritic cells (DCs) recruitment and establishes an immune‐permissive niche through spatiotemporal control over antigen‐adjuvant distribution and prolonged APC‐antigen engagement. Within this niche, DCs efficiently internalize and process TEVs under STING‐mediated activation. These matured DCs subsequently migrate to draining lymph nodes, where they initiate potent and sustained tumor‐specific T‐cell responses. Our results show that rapidly producible personalized vaccines derived from melanoma TEVs effectively inhibit tumor growth. In a postoperative breast cancer model, patient‐tailored TEV vaccines also markedly prevent tumor recurrence and metastasis. This readily customizable platform represents a robust and translatable strategy for personalized cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesExtracellular VesiclesImmunotherapyHydrogelsMembrane ProteinsPrecision MedicineAnimalsDendritic CellsMiceFemaleCell Line, TumorSTING ProteinHumanscGAS-STING Signaling PathwayMice, Inbred C57BL

Stichwörter der Autor:innen

extracellular vesicleimmune nicheimmunotherapypersonalized vaccinesupramolecular hydrogel

Substanzen

Cancer VaccinesHydrogelsMembrane ProteinsSTING ProteinSting1 protein, mouse

Autor:innen und Institutionen

  • School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Medical Molecular Virology of MOE/NHC/CAMS, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

ORCID-Profile: Chenwei Jiang, Liang Dong, Xihui Gao, Feihu Wang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Medicine Engineering Joint Foundation of Shanghai Jiao Tong University

Zitieren

APA

Tang, M., Jiang, C., Guo, M., Chen, Q., Shang, Q., Xiong, L., Zhang, W., Dong, L., Yue, Q., Gao, X., & Wang, F. (2026). Supramolecular STING‐Hydrogel Spatiotemporally Boosts Tumor‐Derived Extracellular Vesicle‐Based Personalized Vaccine for Enhanced Cancer Immunotherapy. Advanced Materials, 38(48). https://doi.org/10.1002/adma.74204

Vancouver

Tang M, Jiang C, Guo M, Chen Q, Shang Q, Xiong L, et al. Supramolecular STING‐Hydrogel Spatiotemporally Boosts Tumor‐Derived Extracellular Vesicle‐Based Personalized Vaccine for Enhanced Cancer Immunotherapy. Advanced Materials. 2026;38(48). doi:10.1002/adma.74204

BibTeX
@article{Tang2026,
  author = {Tang, Minglu and Jiang, Chenwei and Guo, Mingmei and Chen, Qi and Shang, Qi and Xiong, Lin and Zhang, Wen and Dong, Liang and Yue, Qi and Gao, Xihui and Wang, Feihu},
  title = {Supramolecular STING‐Hydrogel Spatiotemporally Boosts Tumor‐Derived Extracellular Vesicle‐Based Personalized Vaccine for Enhanced Cancer Immunotherapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {48},
  doi = {10.1002/adma.74204}
}
Kostenlos starten →